Arcus Biosciences Quote, Financials, Valuation and Earnings

Arcus Biosciences Price Quote

+0.38 (+2.38%)
(Updated: March 23, 2023 at 11:10 PM ET)

Arcus Biosciences Key Stats

Arcus Biosciences (RCUS) is a Sell

Day range:
$15.93 - $16.82
52-week range:
$15.70 - $39.75
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Arcus Biosciences Make?

Is Arcus Biosciences Growing As A Company?

  • What Is Arcus Biosciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.91%
  • What Is Arcus Biosciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arcus Biosciences Stock Price Performance

  • Did Arcus Biosciences Stock Go Up Last Month?
    Arcus Biosciences share price went down by -16.4% last month
  • Did RCUS's Share Price Rise Over The Last Year?
    RCUS share price fell by -53.73% over the past 1 year

What Is Arcus Biosciences 52-Week High & Low?

Arcus Biosciences Price To Free Cash Flow

Is It Risky To Buy Arcus Biosciences?

  • How Much Debt Does Arcus Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arcus Biosciences Have?
    Cash and short term investments quarterly total is $1B
  • What Is Arcus Biosciences’s Book Value Per Share?
    Book value per share is 9.01

Is Arcus Biosciences Cash Flow Positive?

  • What Is RCUS Cash Flow From Operations?
    Cash flow from operations (TTM) is $438M
  • What Is Arcus Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $33M
  • What Is Arcus Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$413M

Arcus Biosciences Return On Invested Capital

  • Is Management Doing A Good Job?
    RCUS return on invested capital is -35.68%
  • What Is Arcus Biosciences Return On Assets?
    ROA measures how assets are converting to revenues and is -18.16%
  • What Is RCUS Return On Equity?
    ROE is a measure of profitability and is -35.68%

Arcus Biosciences Earnings Date & Stock Price

Arcus Biosciences Competitors

Arcus Biosciences Dividend Yield

Data Unavailable

Arcus Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.37%
Revenue: -90.51% 43.34%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 43.25
Upside from Last Price: 170.99%

Major Shareholders

  • How many RCUS shares are owned by institutional investors?
    87M RCUS shares are owned by institutional investors
  • How many RCUS shares are owned by insiders?
    1.7M RCUS shares are owned by insiders